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ABSTRACT
Objective: To investigate differences in outcomes in patients who underwent surgery for insular 
glioma using an awake craniotomy (AC) vs. a craniotomy under general anesthesia (GA).
Methods: Data from patients treated at our hospital between 2005 and 2015 were analyzed 
retrospectively. The preoperative, intraoperative, postoperative, and longer term follow-up 
characteristics and outcomes of patients who underwent surgery for primary insular glioma 
using either an AC or GA were compared.
Results: Of the 52 identified patients, 24 had surgery using an AC and 28 had surgery under 
GA. The extent of resection was similar for the two anesthesia techniques: the median extent 
of resection was 61.4% (IQR: 37.8–74.3%) in the WHO grade <4 AC group vs. 50.5% (IQR: 35.0–
71.2%) in the grade <4 GA group and 73.4% (IQR: 54.8–87.2%) in the grade 4 AC group vs. 88.6% 
(IQR: 61.2–93.0%) in the grade 4 GA group. Consistent with literature, there were more early 
neurological deficits after an AC, while the GA group showed more new late neurological deficits; 
however, these trends were not significant. Survival was similar between the two groups, with 
100% 1- and 2-year survival in the grade <4 groups.
Conclusion: Our results showed that the extent of resection, neurological outcomes, and 
survival were similar using the two anesthesia techniques. Since AC is more challenging for 
the patient and for his or her caregiver after surgery, this finding has implications for clinical 
decision-making.
Introduction
The insular cortex of the brain plays roles in a variety of 
important neurological processes, including somatosen-
sory processing, gustation, balance, control of cardiovas-
cular tone and language [1,2]. Neoplasms, and especially 
gliomas, may cause dysfunction of these processes [1]. 
Insular gliomas represent a substantial portion of all 
central nervous system neoplasms, with 25% of all low-
grade gliomas and 10% of all high-grade gliomas found 
in the insula [3]. The estimated incidence rates are 0.34 
per 100,000 person-years for low-grade insular gliomas 
and 0.41 per 100,000 person-years for high-grade insular 
gliomas [4].
Surgical resection of insular gliomas is challenging 
due to their close proximity to several eloquent cortical 
areas and other critical areas. In addition, the presence 
of critical vascular structures, especially branches of 
the middle cerebral artery, can further complicate the 
procedure [5,6]. Case series of insular gliomal resec-
tions show similar results to other gliomal resection 
according to postoperative cognitive function [7]. 
Furthermore, these studies show that radical resection 
can improve progression-free survival and overall sur-
vival [8–11].
Traditionally, neurosurgeons have had the option 
to resect or debulk an insular glioma either by per-
forming a craniotomy under general anesthesia (GA) 
or by using an awake craniotomy (AC), which allows 
cortical and/or subcortical mapping [12]. The AC pro-
cedure was developed to allow greater resection with 
less risk of damaging eloquent cognitive brain func-
tions [1,13–15]. There is limited evidence regarding the 
best anesthesia technique for resecting these insular 
tumors, and the number of patients in published arti-
cles is relatively low. This is likely due to the technical 
challenges of the procedure and the low incidence of 
the disease.
Many patients with insular tumors have been treated 
at our hospital during the last decade. The data from 
these patients were analyzed to gain a better understand-
ing of this specific patient population and the differences 
in outcomes between the two anesthesia techniques. 
Our aim was to investigate the differences in survival, 
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extent of resection (EOR), and neurological outcomes 
in patients who underwent surgery using AC vs. GA.
Methods
Patients
First, patients were identified who underwent a crani-
otomy under GA or using an AC for the resection or 
debulking of a primary insular glioma between 2005 
and 2015. Patient information was retrieved from the 
electronic patient registry at our hospital. It is routine 
practice to ask neurosurgical patients at intake whether 
they will allow their data to be used anonymously for 
research. Informed consent for the use of all data was 
provided by all of the patients in this retrospective analy-
sis. This study protocol was approved by the ethics board 
at our hospital (MEC 2013-090). The neurosurgeon con-
sulted with the neuro-anesthesiologist and then chose 
which anesthesia technique to use for each patient. 
This clinical choice was investigated in this case series 
in which patients were retrospectively categorized into 
two groups, an AC group and a GA group. All gliomas 
were resected using a transsylvian approach. Data were 
extracted for the entire perioperative (pre-, intra-, and 
post-operative) period and for the follow-up period. All 
data were extracted by the first author, double-checked 
by the last author, and discussed with the co-authors. 
The use of the two anesthesia techniques over time was 
also analyzed.
Preoperative characteristics
The clinical characteristics at presentation and the 
tumor characteristics were determined in order to 
investigate the factors that may have influenced the 
choice of anesthesia technique. The following clini-
cal characteristics were assessed: the presence of lin-
guistic, motor, and sensory dysfunction; whether the 
patient had epilepsy; tumor size at MRI (calculated 
by volumetric analysis); dominant hemispheric local-
ization; and glioma type. Although the tumor glioma 
type could only be confirmed histologically postop-
eratively, radiological presentation often clearly cor-
relates with the pathological diagnosis, especially for 
glioblastoma multiforme (GBM) [16,17]. Therefore, 
the glioma type was used as a preoperative character-
istic. The differences in these variables were analyzed 
between groups in order to assess which factors drove 
the clinical decision.
Intraoperative characteristics
The duration of the procedure, the amount of blood lost, 
and the EOR were compared between the two groups to 
investigate whether the anesthesia type influenced these 
factors. The duration of the procedure was determined 
according to the anesthesia time, which was defined 
as the time in hours between the time-out procedure 
(TOP) and sign-out/extubation/transport to the PACU 
and according to the surgical time, which was defined 
as the time in hours between the first incision and the 
last suture.
Volumetric analysis
Brainlab neuronavigation and planning software (ver-
sion 3.0.0, BrainLAB, Feldkirchen, Germany) was used 
to define the borders of the tumor and to calculate its 
volume in order to assess the percentage of tumor that 
was removed. The volume was calculated both pre- and 
postoperatively using MRI scans that were performed 
as close to the surgical date as possible. In general, a 
T2-weighted or FLAIR MRI was used for low-grade 
gliomas and a T1-weighted MRI with contrast was 
used for high-grade gliomas. The radiology reports 
were used as a reference during each assessment to 
confirm the tumor location and borders. All tumor 
volumes were calculated in cubic centimeters. Cystic 
components were included in the total volume, but 
perifocal edema and intratumoral hemorrhages were 
not. Patients who did not have an MRI scan either 
pre- or postoperatively were excluded from the vol-
ume analysis.
Postoperative characteristics
The early postoperative characteristics were compared 
between the two groups by determining the mean lengths 
of hospital stay and the complications that occurred as 
a result of the procedure. The one- and two-year sur-
vival was determined for all patients, as was the five-
year survival for patients who were operated on before 
September 2012. Survival data for patients that were not 
followed-up at our hospital were obtained by calling each 
patient’s general practitioner.
Neurological outcome
The scale used by De Witt Hamer et al. [18] was used 
to compare neurological outcomes in the two groups. 
Data were retrieved on new-onset postoperative neu-
rological deficits that were categorized as early (up to 
3 months after surgery) and late (3 months or longer 
after surgery), and data on severe and non-severe deficits 
were retrieved as well. Deficits were categorized as severe 
when the patient’s muscle strength was grade 1, 2, or 
to 3 on the Medical Research Council scale or aphasia, 
severe dysphasia, hemianopsia or a vegetative state was 
present. All other deficits were considered non-severe. 
A deficit was scored when it persisted for more than one 
postoperative day and the patient needed an interven-
tion for the deficit.
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Statistical analysis
The clinical outcomes of WHO grade 4 gliomas are 
worse than for other gliomas that have similar effects on 
neurocognitive function at presentation [11,19]; accord-
ingly, grade 4 gliomas were analyzed separately. After 
comparing patients with grade <4 and grade 4 gliomas, 
the GA and AC groups were compared within the grade 
<4 and grade 4 groups.
Normally distributed continuous variables were com-
pared using independent sample t-tests. Non-normally 
distributed non-nominal variables were compared using 
the Mann–Whitney U test and the exact significance 
was reported, while nominal variables were compared 
using Chi-squared (χ2) and Fisher’s exact test when any 
of the categories had an expected count less than 5. To 
assess neurological outcomes, the proportion of patients 
presenting with an early or late deficit and the propor-
tion who suffered from a severe early or late deficit were 
calculated. Neurological outcomes were presented with 
95% CIs. Because survival and EOR were not normally 
distributed, 95% CIs were not reported for these out-
come measures. The EOR was calculated by subtracting 
the preoperative tumor volume by the postoperative vol-
ume and dividing the result by the preoperative tumor 
volume.
To deal with missing data, only available data were 
analyzed. However, the percentages are based on the 
whole group, including missing cases. Because multiple 
hypothesis testing was performed, an α-level of 0.01 was 
considered statistically significant; this was estimated by 
the Bonferroni correction technique [20]. Furthermore, 
a p-value below 0.05 was seen as a trend toward signif-
icance and is discussed as such. The statistical analysis 
was performed using IBM SPSS Statistics 21 (IBM Corp., 
2012. IBM SPSS Statistics for Windows, Version 21.0. 
Armonk, NY: IBM Corp.).
Results
Data were retrieved for 52 patients; of these, 24 patients 
were treated with an AC, and 28 patients were treated 
using a craniotomy under GA. Over time, there was a 
trend toward using AC less often and using GA more 
often in our hospital (Figure 1).
Figure 1. The frequency distribution of the performed techniques over time.
Notes: The bar graph shows the frequency of the procedures in the four indicated time periods. There was a decrease over time in the use of awake craniotomy, 
resulting in greater use of the general anesthesia procedure. Panel a shows the data for all surgeries, and panel b shows the data from surgeries for grade 
<4 gliomas.
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the difference was 41.9  cm3; 95% CI: 7.0–76.8  cm3. 
The tumors were more often localized in the domi-
nant hemisphere in the grade <4 AC group than in 
the grade <4 GA group: 17 (89.5%) vs. 8 (61.5%) 
(p  =  0.021). No such trend toward significance was 
found in the grade 4 groups in terms of localization 
in the dominant hemisphere. However, there was a 
significant difference in the glioma type in the GA 
group vs. the AC group. Specifically, astrocytomas 
were mostly resected using GA, while oligodendro-
gliomas were all resected using an AC. GBM was more 
often treated under GA. The p-value was <0.001 for 
these differences.
Intraoperative and postoperative characteristics
Table 3 shows the intraoperative and postoperative char-
acteristics of the patients in the GA and AC groups.
Surgical duration
There was a trend toward significance for differ-
ences in anesthesia time in the GA group according 
to tumor grade: the anesthesia time was 6.4 ± 1.2 h 
for the grade <4 GA group and 5.0  ±  2.1  h for the 
grade 4 GA group (p = 0.036; mean difference, 1.4 h; 
95% CI: 0.10–2.8  h). Post-hoc analysis showed a 
trend toward significance regarding the duration of 
anesthesia induction and preparation of the patient 
in the GA group: the time between the TOP and the 
incision was 1.2 ± 0.13 h for patients in the grade <4 
GA group vs. 0.99 ± 0.24 h for patients in the grade 
<4 GA group (p = 0.02; mean difference, 0.19 h; 95% 
CI: 0.032–0.34 h).
Surgical characteristics
The intraoperative blood loss was higher in the grade 
<4 AC group, which showed a mean blood loss of 
584  ±  214  ml vs. 307  ±  188  ml in the grade <4 GA 
group (p  =  0.001; mean difference, 277  ml; 95% CI: 
127–427  ml). There was no difference in blood loss 
between the grade 4 GA group vs. the grade 4 AC group 
or between the grade 4 and the grade <4 glioma groups 
within the two groups. Even though blood loss was 
greater in the grade <4 AC group, none of the patients 
received a blood transfusion. The EOR was similar in 
the grade <4 groups and in the grade 4 groups, but 
the EOR in the grade 4 GA group was significantly 
higher than in the grade <4 GA group: 82.4% (IQR: 
60.1–92.8%) in the grade 4 group, and 50.5% (IQR: 
35.0–71.2%) in the grade <4 group (p = 0.003) (Figure 
2). One patient was excluded from the analysis because 
a postoperative MRI scan was not available, as the 
patient had pneumonia and was in the intensive care 
unit for 20 days. An MRI has not been performed in 
the ICU.
Patient characteristics
The groups were similar for all descriptive variables 
except age (Table 1). The mean age was 55.2 ± 16.0 years 
for patients in the grade 4 GA group vs. 41.9 ± 10.5 years 
for patients in the grade <4 GA group (p = 0.017; 95% 
CI: 2.6–24.0  years). There were no significant differ-
ences in age between the patients in the two anesthesia 
groups.
Variables that could influence the choice to use AC 
versus GA
Table 2 shows an overview of the variables that could 
influence the choice to use AC vs. GA.
Clinical presentation
There were no significant differences in linguistic and 
motor dysfunction between the AC and GA groups. 
There was a trend toward statistical significance for 
differences in sensory dysfunction at presentation 
according to tumor grade in the GA group: 3 (23.1%) 
patients in the grade <4 GA group suffered from sen-
sory dysfunction vs. 9 (60.0%) patients in the grade 4 
GA group (p = 0.049). There was also a trend toward 
statistical significance for differences in epilepsy 
according to tumor grade in the GA group: 8 (53.3%) 
patients in the grade 4 GA group suffered from epi-
lepsy vs. 12 (92.3%) patients in the grade <4 GA group 
(p = 0.038).
The tumor size was similar in the two groups for 
both grade <4 tumors and for grade 4 tumors. There 
was a trend toward statistical significance for differ-
ences in tumor size according to tumor grade in the 
GA group: 54.6 ± 25.4 cm3 in the grade <4 GA group 
vs. 96.5 ± 59 cm3 in the grade 4 GA group (p = 0.02); 
Table 1. characteristics of the 52 patients who underwent 
primary resection for insular glioma at the erasmus university 
Medical center 2005–2015.
Notes: There was only one significant difference between any of the groups 
(grade 4 vs. grade <4 within the ac and ga groups or ac vs. ga within 
the grade 4 and grade <4 groups). That difference was for age, which 
was significantly different (p = 0.017) between the grade 4 ga group and 
the grade <4 ga group (95% ci: 2.6–24.0 years).
Variable
Awake craniotomy (AC) General anesthesia (GA)
WHO 
grade <4 
n = 19
WHO 
grade 4 
n = 5
WHO 
grade <4 
n = 13
WHO 
grade 4 
n = 15
age at surgery 
in years, 
mean ± sD
41.1 ± 11.8 41.5 ± 6.3 41.9 ± 10.5 55.2 ± 16.0
Male, n (%) 16 (84.2%) 4 (80%) 8 (61.5%) 10 (66.7%)
Weight in kg, 
mean ± sD
86.5 ± 12.3 79.6 ± 11.8 85.5 ± 20.9 88.7 ± 14.6
height in m, 
mean ± sD
1.80 ± 0.08 1.83 ± 0.05 1.80 ± 0.12 1.80 ± 0.12
BMi in kg/m2, 
mean ± sD
26.1 ± 2.97 23.8 ± 2.8 26.1 ± 4.11 27.8 ± 5.8
right handed, 
n (%)
14 (73.7%) 5 (100%) 10 (76.9%) 11 (73.3%)
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developed in 48% (95% CI 26–70%) of the patients in the 
GA group and in 33% (95% CI: 10–56%) of the patients 
in the AC group. Severe late onset deficits developed in 
12% (95% CI: 0–27%) of patients in the GA group and 
in 5% (95% CI: 0–17%) of the patients in the AC group. 
None of the differences between the groups were signif-
icant. The groups were too small to analyze differences 
between grade 4 and grade <4 groups (Figure 4).
Summary
To summarize, a total of 52 patients underwent primary 
insular glioma resection at our hospital. This retrospec-
tive case series analysis found that over the course of the 
study period, the GA procedure was used more often 
than the AC procedure. Astrocytomas and GBMs were 
more often treated under GA, while oligodendrogliomas 
were more often treated using AC. Intraoperative blood 
Postoperative characteristics
The length of hospital stay was similar in the AC and 
GA groups. Table 4 shows the complications. The one-, 
two-, and five-year survival rates were higher in the 
grade <4 groups than in the grade 4 groups. No differ-
ence between AC and GA was found according to one-, 
two-, and five-year survival (Figure 3). The five-year 
survival time could be determined for the AC group, 
but some information was missing for the GA group.
Neurological outcome
Early onset deficits developed in 67% (95% CI: 46–88%) 
of the patients in the AC group and in 57% (95% CI: 
37–77%) of the patients in the GA group. Severe early 
onset deficits developed in 25% (95% CI: 6–44%) of the 
patients in the AC group and in 11% (95% CI: 0–24%) 
of the patients in the GA group. Late onset deficits 
Table 2. Preoperative clinical characteristics of the 52 patients who underwent primary resection for insular glioma at the erasmus 
university Medical center 2005–2015.
Variable
Awake craniotomy (AC) General anesthesia (GA) P-value for AC vs. GA
P-value for WHO grade 
<4 vs. grade 4
WHO grade 
<4 n = 19
WHO grade 4 
n = 5
WHO grade 
<4 n = 13
WHO grade 4 
n = 15
WHO grade 
<4 WHO grade 4 AC GA
clinical presenta-
tion
linguistic 
dysfunction, 
n (%)
11 (57.9%) 4 (80%) 3 (23.1%) 7 (46.7%) n.s. n.s. n.s. n.s.
Motor dysfunc-
tion, n (%)
6 (31.6%) 2 (40.0%) 5 (38.5%) 5 (33.3%) n.s. n.s. n.s. n.s.
sensory dysfunc-
tion, n (%)
8 (42.1%) 3 (60.0%) 3 (23.1%) 9 (60.0%) n.s. n.s. n.s. 0.049
epilepsy, n (%) 11 (57.9%) 3 (60%) 12 (92.3%) 8 (53.3%) n.s. n.s. n.s. 0.038
Tumor size at 
presentation in 
cm3, mean ± sD
61.2 ± 24.5 107.2 ± 62.1 54.6 ± 25.4 96.5 ± 59 n.s. n.s. n.s. 0.02
Tumor in 
dominant 
hemisphere, 
n (%)
17 (89.5%) 4 (80%) 8 (61.5%) 5 (33.3%) 0.021 n.s. n.s. n.s.
histological 
classification, 
n (%)
astrocytoma 6 (31.6%) – 13 (100%) – 0.001 – <0.001 <0.001
oligodendro-
glioma
10 (52.6%) – 0 (0%) –
Mixed 3 (15.8%) – 0 (0%) –
glioblastoma – 5 (100%) – 15 (100%)
Table 3. intraoperative and postoperative characteristics of the surgeries for primary insular glioma.
Variable
Awake craniotomy (AC) General anesthesia (GA) P-value for AC vs. GA
P-value for WHO grade 
<4 vs. grade 4
WHO grade 
<4 n = 19
WHO grade 4 
n = 5
WHO grade 
<4 n = 13
WHO grade 4 
n = 15
WHO grade 
<4 WHO grade 4 AC GA
anesthesia 
time in hours, 
mean ± sD
5.6 ± 1.2 5.0 ± 0.8 6.4 ± 1.2 5.0 ± 2.1 n.s. n.s. n.s. 0.036
surgical time 
in hours, 
mean ± sD
4.2 ± 1.1 3.6 ± 0.6 5.0 ± 1.1 3.8 ± 1.9 n.s. n.s. n.s. n.s.
Blood lost in ml, 
mean ± sD
584 ± 214 860 ± 456 307 ± 188 436 ± 373 0.001 n.s. n.s. n.s.
length of hospi-
tal stay in days, 
median (iQr)
7 (6–9) 9 (8–12) 9 (7–11) 7 (6–13) n.s. n.s. n.s. n.s.
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Discussion
This retrospective analysis of patients with insular gli-
omas who were treated by an AC or by a craniotomy 
under GA was performed to gain insights into the effects 
of these two techniques on the patients, especially on 
EOR, survival, and neurological outcome.
Choice of anesthesia technique
In the later part of the investigated period, the GA tech-
nique was preferred over the AC technique because 
the GA procedure is less challenging for the patient 
and has advantages for the doctors. GA was also pre-
ferred for grade 4 gliomas, which more often present 
perivascularly and with adhesions to the M2 and M3 
branches of the middle cerebral artery [21]. Pressure 
on these branches is painful for AC patients, so GA is 
typically used for grade 4 gliomas. The neurosurgeons 
at our hospital found that surgeries performed using 
AC were often quite long; the patients became fatigued, 
reducing the advantages of performing an awake sur-
gery. Since craniotomy under GA showed good results, 
neurosurgeons who became comfortable resecting these 
tumors more often opted to use GA. However, AC was 
still preferred for patients with frontal opercular exten-
sion, especially when the dominant frontal operculum 
was involved and the patients presented with speech 
problems following an epileptic insult. Indeed, patients 
were more often treated with an AC if they presented 
loss was greater in patients with grade <4 tumors in the 
AC group than in the GA group. The EOR was similar 
between the AC and GA groups, but the mean EOR was 
greater in the grade 4 GA group than in the grade <4 
GA group. The one-, two-, and five-year mortality was 
similar between the AC and GA groups, but patients 
with grade 4 gliomas had worse survival than those with 
grade <4 tumors. New early deficits were more preva-
lent in the AC group, and new late deficits were more 
prevalent in the GA group, but the differences were not 
significant.
Figure 2. a box plot shows the median extent of resection (eor) and the 1st and 3rd quartiles for each group of patients.
Note: The grade 4 patient groups had a larger extent of resection, and this difference was significant between the grade <4 and grade 4 ga groups (p = 0.002).
Table 4. summary of the surgical complications that occurred 
after surgical resection and before discharge in the 52 patients 
who underwent primary resection for insular glioma at the 
erasmus university Medical center 2005–2015.
*1 patient underwent a recraniotomy.
Awake craniot-
omy (n = 24)
General anesthe-
sia (n = 28) Total n
Complication
Postoperative insult 1 1 2
Periorbital edema 3 0 3
atelectasis 0 1 1
Postoperative 
hemorrhage
2* 0 2
headache 1 2 3
hyperglycemia 1 1 1
Nausea 1 1 2
Pulmonary embo-
lism
0 1 1
urinary tract 
infection
1 0 1
Pneumonia 0 1 1
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allow resection while ensuring clear demarcation of 
the functional language area in order to preserve this 
 function [23].
Oligodendrogliomas were more often operated on 
using AC, and astrocytomas more often resected under 
with a tumor localized in their dominant hemisphere. 
Note that linguistic dysfunction as a symptom did not 
differ significantly between the groups. Because linguis-
tic function resides mostly in the dominant hemisphere 
[22], AC may have been chosen for these patients to 
Figure 3. a bar graph shows the proportion of patients who were alive one, two, and five years after surgery.
Note: in the general anesthesia (ga) group, information on five-year survival was not available for 4 (30.8%) patients in the grade <4 ga group or for 7 (46.7%) 
patients in the grade 4 ga group.
Figure 4. a box plot shows the proportions and 95% confidence intervals of patients with newly developed, any early, severe early, 
any late, or severe late neurological deficits.
Notes: More early neurological deficits were seen in the awake craniotomy group, while more late neurological deficits were seen in the general anesthesia 
group. This trend was seen for any deficits and for severe deficits, but none of the differences reached statistical significance.
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performed in the second half of the study period, data 
were not available for some patients for the five-year 
survival analysis, and conclusions regarding five-year 
survival cannot be drawn. Our results indicated that one 
and two years after surgery for insular glioma, there were 
no differences in survival using AC vs. GA.
Other findings
In the GA group, patients in the grade <4 group were 
younger than patients in the grade 4 group and more 
often presented with epilepsy. These findings can be 
explained by differences in the pathogenesis of primary 
and secondary GBM. Primary GBMs are most likely 
derived from neurological progenitor cells, while second-
ary GBMs are most likely derived from dedifferentiated 
glial cells [26]. Primary GBMs are more frequently diag-
nosed and often express wild type isocitrate dehydroge-
nase 1 or 2 (IDH1/2); in contrast, 73–88% of the patients 
with secondary GBMs express mutated IDH1 or IDH2 
[26]. The epidemiological distribution of IDH1/2 muta-
tions, which are associated with epilepsy, in the types of 
GBMs could explain the lower frequency of epilepsy in 
the grade 4 group in our population. It is more likely that 
this group mostly had primary GBMs that expressed wild 
type IDH1/2, which would explain the lower prevalence 
of epilepsy in the grade 4 group than in the grade <4 
group [27]. Since epilepsy is a symptom that can be sug-
gestive of brain tumors, secondary GBMs might be diag-
nosed in an earlier stage, e.g. as an astrocytoma, which 
could explain the lower prevalence of secondary GBMs as 
well as the younger age at which they are diagnosed [26].
Intraoperatively, blood loss was greater in the grade 
<4 AC group than in the grade <4 GA group. This can be 
explained by the higher mean arterial blood pressure in 
awake patients. There was no indication that this results 
in a clinically relevant difference in outcome.
The anesthesia time was longer in the grade <4 GA 
group than in the grade 4 GA group. The 1.4-h difference 
between the groups could not be explained by the suba-
nalysis, which showed a difference of 0.2 h between the 
induction and preparation time between the grade <4 GA 
group and the grade 4 GA group. The difference between 
these groups cannot be fully explained. However, it can 
be more difficult to determine the borders of an insular 
LGG than the borders of an HGG, and therefore for this 
step may take longer when treating insular LGGs.
Limitations
This study had some limitations. First, this was a retro-
spective, single-center study of a disease that has a low 
incidence, so a larger sample size was not available. Some 
real differences may have been missed because of the size 
of the study. However, the sample size was comparable to 
or even larger than studies that have been published pre-
viously by other groups. Because the insula is a relatively 
GA. This is most likely because oligodendrogliomas 
are more often located in the frontal operculum than 
astrocytomas; therefore, AC is more often used for these 
tumors. A study on the use of AC for the resection of 
tumors in eloquent areas showed that all tumors had an 
oligodendrogliomal component [24].
Outcomes
The EOR was similar using AC and GA, but the EOR was 
smaller within the GA group for grade <4 tumors than 
for grade 4 tumors. This group also had a larger preop-
erative tumor volume, and this might explain the higher 
EOR. Since the edges of the tumor are the most difficult 
to resect, a larger tumor with a smaller surface area- 
to-volume ratio, could result in a higher EOR. In addition, 
GBMs with central necrosis are easier to distinguish from 
normal brain tissue than are low grade gliomas, allowing 
easier resection without the need to map the region. In 
the literature, the median EOR for insular gliomas varies 
from 83.4 to 86.2% [7,10,23]. However, only Lang et al. 
reported the EOR for the non-glioblastoma group sepa-
rately (median EOR, 86%) [5]. However, it seemed that 
in this study, the population that presented with grade <4 
tumors mainly had small diffuse tumors that were hard 
to resect. Diffuseness was not measured, so it cannot be 
compared to reports in the literature, but tumor size was 
measured. The mean tumor size was 61.2 cm3 in the AC 
group and 54.6 cm3 in the GA group, which contrasts 
with, for example, the mean tumor size of 107.7  cm3 
reported in the study by Alimohamadi et al. [23].
The neurological outcomes observed in our popu-
lation suggested that the AC results in fewer late neu-
rological deficits than the GA technique, although the 
difference was not significant. For a power of 80%, a 
sample size of 49 per group would be needed to find the 
same difference in the occurrence of early deficits, as in 
the study by De Witt Hamer et al. (α = 0.01) [18]. For 
a power of 80%, a sample size of 1953 per group would 
be needed to detect the same difference in late deficits 
using the same assumptions. These larger sample sizes 
may not be attainable for this rare disease. Nevertheless, 
the trends of more early onset neurological deficits after 
AC and more late onset neurological deficits after GA 
are consistent with the literature [18]. De Witt Hamer 
et al. hypothesized that an AC enables more extended 
resection and more tumor control, resulting in the pres-
ervation of neurological functions that can be mapped at 
the cost of early transient neurological deficits.
Differences in 1- and 2-year mortality were not 
observed between the two anesthesia groups. GA was 
preferred for the treatment of astrocytomas, which have 
a worse survival prognosis than oligodendrogliomas 
[11,25]. This apparent contradiction is explained by the 
small sample size in this study. Furthermore, the liter-
ature suggests that survival curves start to diverge after 
more than two years. Since most GA procedures were 
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common location for gliomas [3] and because insu-
lar gliomas have distinctive clinical features [10], this 
patient population is worth analyzing. Considering the 
low incidence of insular glioma, this study contributes 
to the existing body of knowledge about these patients.
Second, patients with WHO grade 4 glioma were com-
pared with patients with grade <4 glioma, but it could be 
argued that WHO grade 3 and 4 groups should have been 
compared with WHO grade 1 and 2 groups. In this study, 
patients were divided based on similar clinical presenta-
tion and survival, but other authors have frequently 
grouped patients with grade 3 glioma with patients with 
grade 4 glioma [7]. However, the grade 4 group in this 
study was large enough to merit its own group, especially 
considering the distinctive clinical features of GBMs.
Finally, there are some limitations due to the retro-
spective design of the study, and additional prospective 
studies are needed to validate these observations. The 
advantage of our approach is that it provides a starting 
point for further study of additional research questions. 
For example, these results suggest that the value of AC 
for patients who present with linguistic dysfunction 
should be investigated further, as should the possible 
clinical relevance of higher blood loss during AC vs. GA.
Notably, there is an alternative technique that can be 
used to protect motor function in which the cortical pro-
cesses are mapped using motor evoked potentials while 
the patient is under GA [28]. However, this technique 
was not performed at our hospital before 2015, so it is 
not discussed in this case series. It may be interesting to 
evaluate tumor extension into the temporal or frontal 
operculum as well as tumor extension medially beyond 
the lenticulostriate perforators; however, the subgroups 
were too small to draw any conclusions.
Use of the transcortical approach for the resection 
of this type of tumor is another technique that is not 
performed in our hospital, even though it may provide 
greater exposure of the insula and therefore might facil-
itate a greater EOR [29]. However, in our experience, 
this technique is not in widespread use, plus it should be 
critically evaluated as it involves the use of an approach 
through healthy brain tissue.
Conclusion
AC was used more often for the resection of dominant 
hemispheric tumors and oligodendrogliomas, while 
GA was used more often for astrocytomas and GBMs. 
However, both anesthesia techniques resulted in similar 
EORs, similar neurological outcomes, and similar one- 
and two-year survival in patients with similar tumor 
grades. Therefore, the added value of the more challeng-
ing AC procedure should be carefully considered for 
each patient. Prospective studies are needed to further 
evaluate the relative value of these techniques.
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